2018
Botulinum Toxin in Restless Legs Syndrome—A Randomized Double-Blind Placebo-Controlled Crossover Study
Mittal SO, Machado D, Richardson D, Dubey D, Jabbari B. Botulinum Toxin in Restless Legs Syndrome—A Randomized Double-Blind Placebo-Controlled Crossover Study. Toxins 2018, 10: 401. PMID: 30274305, PMCID: PMC6215171, DOI: 10.3390/toxins10100401.Peer-Reviewed Original ResearchConceptsRestless legs syndromePain scoresCrossover studyLegs syndromePlacebo-controlled crossover studyDouble-blind placeboPatient Global ImpressionVisual analog scalePrevious smaller studiesCommon movement disorderQuality of lifeIncobotulinumtoxin APlacebo groupRLS symptomsAnalog scaleGlobal ImpressionOnabotulinumtoxin ALife QuestionnaireTibialis anteriorBotulinum toxinNormal salineMovement disordersRLS scoresSmall studyFemoris muscle
2017
Botulinum Toxin in Parkinson Disease Tremor A Randomized, Double-Blind, Placebo-Controlled Study With a Customized Injection Approach
Mittal SO, Machado D, Richardson D, Dubey D, Jabbari B. Botulinum Toxin in Parkinson Disease Tremor A Randomized, Double-Blind, Placebo-Controlled Study With a Customized Injection Approach. Mayo Clinic Proceedings 2017, 92: 1359-1367. PMID: 28789780, DOI: 10.1016/j.mayocp.2017.06.010.Peer-Reviewed Original ResearchConceptsDisease Rating ScaleHand weaknessPatients' perceptionsUnified Parkinson's Disease Rating ScaleParkinson's Disease Rating ScaleAdministration of onabotulinumtoxinASevere hand weaknessUse of onabotulinumtoxinAPatient Global ImpressionClinical rating scoresTreatment of tremorParkinson's disease tremorIncobotulinumtoxinA injectionsCrossover trialGlobal ImpressionGrip strengthRest tremorBotulinum toxinPD tremorPostural tremorTreatment efficacyClinical practiceSignificant improvementEssential tremorHand strength
2008
Sensory physiology assessed by evoked potentials in survivors of poliomyelitis
Prokhorenko OA, Vasconcelos OM, Lupu VD, Campbell WW, Jabbari B. Sensory physiology assessed by evoked potentials in survivors of poliomyelitis. Muscle & Nerve 2008, 38: 1266-1271. PMID: 18816600, DOI: 10.1002/mus.21093.Peer-Reviewed Original ResearchMeSH KeywordsAfferent PathwaysAgedAged, 80 and overAtrophyBrainCohort StudiesDisability EvaluationDisease ProgressionElectric StimulationElectroencephalographyEvoked Potentials, SomatosensoryFemaleHumansMagnetic Resonance ImagingMaleMiddle AgedNeural ConductionPoliomyelitisPostpoliomyelitis SyndromeSensation DisordersSensory Receptor CellsSeverity of Illness IndexSpinal CordSurvivorsConceptsMagnetic resonance imagingPolio survivorsLower limb SEPsPatches of atrophySurvivors of poliomyelitisUpper limb SEPsProportion of patientsAbnormal SEPsElectrographic findingsSensory lossMean ageSensory deficitsSpinal cordSensory abnormalitiesSensory impairmentPatientsSensory pathwaysSensory functionSEP studiesResonance imagingPoliomyelitisSurvivorsSensory problemsSEPsFurther studies